Advances in molecular pathogenesis and clinical therapy of multiple myeloma: a 2013 EHA annual meeting press releases / 白血病·淋巴瘤

Multiple myeloma (MM) is a genetically complex disease that is becoming more common in today' s aging population.In the 18th European Hematology Association (EHA) annual meeting,there were a number of key topics focusing on the development of MM from intraclonal heterogeneity,novel therapeutic agents,and relapse and refractory MM therapy,etc.